-
Citigroup Cuts Mosaic To Neutral, Says Phosphate Supply Outstrips Demand
Friday, March 29, 2019 - 11:41am | 363Read More...With the entry of new competitors, phosphate fundamentals have weakened, according to Citigroup. Moves by Mosaic Co (NYSE: MOS) to improve supply dynamics by curtailing capacity are unlikely to result in a significant upturn, the sell-side firm said in a Friday downgrade. The Analyst...
-
Citi's Chemicals And Agriculture Pair Trade: Buy Mosaic, Hold Sherwin-Williams
Thursday, October 11, 2018 - 10:54am | 483Read More...In a preview of third-quarter earnings in the chemical and agriculture sector, Citigroup highlighted a pair trade in the sector. The sell-side firm recommended buying Mosaic Co (NYSE: MOS) but moving to the sidelines on Sherwin-Williams Co (NYSE: SHW). The Analyst Analyst P.J. Juvekar...
-
Citi Moves CF Industries To Neutral, Says Near-Term Outperformance 'May Be Difficult'
Tuesday, March 13, 2018 - 1:55pm | 440Read More...CF Industries Holdings, Inc. (NYSE: CF) shares have jumped 42 percent over the past year, prompting a downgrade by Citi on valuation. The Analyst Citi analyst P.J. Juvekar downgrades shares of CF Industries from Buy to Neutral and lowered the price target from $47 to $45. The Thesis CF...
-
Pullback Provides Entry Point In Chemours; Citi Upgrades
Wednesday, July 5, 2017 - 11:57am | 274Read More...Citi analyst P.J. Juvekar sees now as the perfect time to buy Chemours Co (NYSE: CC) stock, as he upgraded his rating to Buy with a $45 price target. “We think the recent pullback offers a good entry point. Our investment thesis is primarily based on: 1) Excellent regulation driven growth for...
-
Citi Gives Their Take On Potential Potash-Agrium Tie-Up
Wednesday, August 31, 2016 - 8:31am | 361Read More...Potash Corporation of Saskatchewan (USA) (NYSE: POT) confirmed that it is in the midst of merger talks with Agrium Inc. (USA) (NYSE: AGU). Among all the fertilizer companies, the Potash-Agrium merger “makes most sense to us,” Citi’s P.J. Juvekar said in a report. He maintained a...
-
Citi Upgrades Ecolab, Citing Its Defensive Portfolio And Energy Segment Growth
Wednesday, August 3, 2016 - 8:18am | 337Read More...Ecolab Inc’s (NYSE: ECL) Energy business seems to be approaching an inflection point, Citi’s P.J. Juvekar said in a report. He upgraded the rating on the company from Neutral to Buy, while raising the price target from $127 to $141. Robust Growth In Defensive Portfolio Ecolab...
-
If Bayer Deal Falls Through, Could Monsanto See $92 Handle?
Friday, July 1, 2016 - 3:29pm | 409Read More...Shares of Monsanto Company (NYSE: MON) could drop to about $92 if the potential deal with Bayer AG (ADR) (OTC: BAYRY) fails to take off. In May, Germany's Bayer offered to buy Monsanto for $62 billion, or $122 a share. Monsanto rejected the offer terming it as "incomplete and financially inadequate...
-
Albemarle Accelerates Toward De-Levering, Growth Story On Track
Tuesday, June 28, 2016 - 9:44am | 247Read More...Albemarle Corporation (NYSE: ALB)'s Chemetall sale "accelerates path to de-levering." Citi Bank's P.J. Juvekar reiterates his Buy rating on Albemarle, the top pick on Citi's focus list, with a price target of $89. The company's surface treatment (Chemetall) business was bought at a fair price,...
-
Bayer's Monsanto Acquisition Unlikely To Happen, Says Citi
Friday, May 20, 2016 - 8:13am | 275Read More...Citi’s P.J. Juvekar believes the acquisition of Monsanto Company (NYSE: MON) by Bayer is unlikely to occur, given the potential synergies, divestitures needed, regulatory concerns and more. Juvekar maintains a Neutral rating on Monsanto, with a price target of $94. Synergies The analyst...
-
Citi Downgrades Monsanto Amid Agriculture Downturn
Monday, March 14, 2016 - 9:12am | 305Read More...Citi’s P.J. Juvekar downgraded the rating for Monsanto Company (NYSE: MON) from Buy to Neutral, while reducing the price target from $105 to $95. The analyst cited agricultural downturn and its impact on the company as the reasons for the downward revisions. In the current Ag downturn,...
-
Buy Sherwin-Williams, Sell Valspar? These Guys Are
Thursday, March 3, 2016 - 10:34am | 264Read More...Citi's P.J. Juvekar upgraded the rating for Sherwin-Williams Co (NYSE: SHW) from Neutral to Buy, while raising the price target from $281 to $316. He expects the company's shares to be driven by the good response to the company's Infinity product line at Lowe's Companies, Inc. (NYSE: LOW) stores....
-
Citi Sees Gains For Monsanto In Potential Syngenta Deal
Tuesday, June 23, 2015 - 3:22pm | 295Read More...Monsanto Company (NYSE: MON) could boost profits by 13 percent with its propose acquisition of Syngenta AG (NYSE: SYT), an analyst said Tuesday. Citi's P.J. Juvekar said a deal would boost Monsanto's annual earnings by $0.90 a share. Analysts on average now expect Monsanto will post...
-
Citigroup Moves To The Sidelines With LyondellBasell Downgrade
Tuesday, February 17, 2015 - 12:23pm | 187Read More...Following a recent rally in the company's stock price, Citigroup issued a report on LyondellBasell Industries NV (NYSE: LYB). Citigroup lowered LyondellBasell's rating from Buy to Neutral and lowered their price target from $101 to $96. Analyst P.J. Juvekar and John Hirt wrote, "LyondellBasell...
-
Citi Analyst Touts Pending Monsanto Product Launch
Monday, January 12, 2015 - 3:57pm | 240Read More...Monsanto Company (NYSE: MON) is plowing into a near-term headwind from a corn glut, but its product pipeline ensures healthy earnings growth in the longer term, an analyst said Monday. Citi's P.J. Juvekar said the company's expected launch of its Roundup Xtend crop system for soybean...
-
UPDATE: Citigroup Downgrades CF Industries
Thursday, April 3, 2014 - 12:55pm | 119Read More...On Thursday, Citigroup downgraded shares of CF Industry (NYSE: CF) from Buy to Neutral and maintained a $267 price target. Analyst P.J. Juvekar seems “limited catalysts near term” as the stock nears the analyst's previous $267 price target. Juvekar is complimentary of management for recent...
